Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo

被引:27
作者
Anderson, Leah J. [1 ]
Longnecker, Richard [1 ]
机构
[1] Northwestern Univ, Dept Microbiol & Immunol, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
REED-STERNBERG CELLS; T-CELL; TRANSCRIPTION FACTORS; RECEPTOR SIGNAL; EBV LMP2A; PRO-B; HODGKIN; EXPRESSION; LINEAGE; MICE;
D O I
10.1182/blood-2008-06-160937
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Expression of latent membrane protein 2 (LMP2A) during B-cell development leads to global alterations in gene transcription similar to those seen in Hodgkin Reed-Sternberg cells of Hodgkin lymphoma (HL). Along with the consistent detection of LMP2A in Epstein-Barr virus associated HL, this implicates a role for LMP2A in the pathogenesis of HL. We have shown that LMP2A constitutively activates the Notch1 pathway to autoregulate the LMP2A promoter. To determine whether constitutive activation of the Notch pathway is important for LMP2A-mediated alterations in B-cell development in vivo, TgE-LMP2A-transgenic mice were intercrossed with mice expressing IoxP-flanked Notch1 genes and Cre recombinase. B cells from TgE Notch1(lox/lox)-CD19(+/Cre) mice have an increase in immunoglobulin M and CD43 and a decrease in CD5 expression in the bone marrow compared with TgE Notch1(lox/lox) mice, indicating the LMP2A signal for developmental aberrations is impaired in the absence of Notch1. Real-time reverse-transcribed polymerase chain reaction analysis reveals that LMP2A requires the Notch1 pathway to alter levels of B cell-specific transcription factors, E2A and EBF. Interestingly, Notch1 appears to be important for LMP2A-mediated survival in low interleukin-7. We propose that LMP2A and the Notch1 pathway may cooperate to induce the alterations in B-cell identity seen in Hodgkin Reed-Sternberg cells. (Blood. 2009; 113: 108-116)
引用
收藏
页码:108 / 116
页数:9
相关论文
共 50 条
[1]   EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway [J].
Anderson, Leah J. ;
Longnecker, Richard .
JOURNAL OF GENERAL VIROLOGY, 2008, 89 :1563-1568
[2]   An auto-regulatory loop for EBV LMP2A involves activation of Notch [J].
Anderson, Leah J. ;
Longnecker, Richard .
VIROLOGY, 2008, 371 (02) :257-266
[3]   Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cells [J].
Bertrand, FE ;
Eckfeldt, CE ;
Lysholm, AS ;
LeBien, TW .
LEUKEMIA, 2000, 14 (12) :2095-2102
[4]   Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EμLMP2A transgenic mice [J].
Caldwell, RG ;
Brown, RG ;
Longnecker, R .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1101-1113
[5]   Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals [J].
Caldwell, RG ;
Wilson, JB ;
Anderson, SJ ;
Longnecker, R .
IMMUNITY, 1998, 9 (03) :405-411
[6]   B cell receptor signal strength determines B cell fate [J].
Casola, S ;
Otipoby, KL ;
Alimzhanov, M ;
Humme, S ;
Uyttersprot, N ;
Kutok, JL ;
Carroll, MC ;
Rajewsky, K .
NATURE IMMUNOLOGY, 2004, 5 (03) :317-327
[7]   Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes [J].
Chaganti, S ;
Bell, AI ;
Pastor, NB ;
Milner, AE ;
Drayson, M ;
Gordon, J ;
Rickinson, AB .
BLOOD, 2005, 106 (13) :4249-4252
[8]   Density of the Notch ligand Delta1 determines generation of B and T cell precursors from hematopoietic stem cells [J].
Dallas, MH ;
Varnum- Finney, B ;
Delaney, C ;
Kato, K ;
Bernstein, ID .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) :1361-1366
[9]   Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironment [J].
De Smedt, M ;
Hoebeke, I ;
Reynvoet, K ;
Leclercq, G ;
Plum, J .
BLOOD, 2005, 106 (10) :3498-3506
[10]   EPSTEIN-BARR-VIRUS AND HODGKINS-DISEASE - TRANSCRIPTIONAL ANALYSIS OF VIRUS LATENCY IN THE MALIGNANT-CELLS [J].
DEACON, EM ;
PALLESEN, G ;
NIEDOBITEK, G ;
CROCKER, J ;
BROOKS, L ;
RICKINSON, AB ;
YOUNG, LS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :339-349